Bright times: 83% of execs plan to invest in telehealth

Cara Livernois | | Health Exec | Telehealth

The American Telemedicine Association (ATA), having released its 2017 Telemedicine Executive Leadership Survey, found that 83 percent of healthcare executives plan to invest in telehealth.

Telehealth is rapidly becoming an alternative avenue for accessing care for patients in rural areas and those seeking outside specialists. While patients demand increased access to telehealth, the survey showcases how healthcare executives are invested in providing services.

“This executive leadership survey confirms undeniably today’s leaders view telemedicine as a major driver in transforming healthcare,” said Jonathan Linkous, CEO, American Telemedicine Association. “It comes as no surprise that 98 percent of survey respondents believe telehealth services create a competitive advantage, and I anticipate tremendous growth in the market as we continue to move toward more patient-centered solutions.”

Read more here:

ATA Leadership Survey: Patient-centered Healthcare and EHR Interoperability Cit…

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

Amazon One Medical sued after patient prescribed inhaler dies in ER
DEA, HHS extend telehealth controlled substance prescription rule
Association of 300 telehealth groups urges Congress to extend COVID-era rules
Eli Lilly releases cheaper, single-use vials of weight loss drug
Walmart sells virtual care business to Fabric
AMA will aggressively support permanent telemedicine reimbursement

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.